SELLAS Life Sciences Group Inc. Common Stock vs The Travelers Companies Inc. Common Stock — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B), while The Travelers Companies Inc. Common Stock trades at $369.66 (market cap $75.21B). The key difference: The Travelers Companies Inc. Common Stock is far larger — about 33× SELLAS Life Sciences Group Inc. Common Stock's market cap, and The Travelers Companies Inc. Common Stock pays a 1.39% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| SLS | TRV | |
|---|---|---|
Market Cap | $2.28B | $75.21B |
Volume | 3,128,960 | 1,008,435 |
Sector | Health | Financials |
52-Week High | $15.46 | $397.22 |
52-Week Low | $1.39 | $261.57 |
Enterprise Value | $2.15B | $83.80B |
Typical Hold Time | — | 0 Days |
Dividend Yield | — | 1.39% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →The Travelers Companies provides property and casualty insurance for individuals, businesses, and organizations. Its products include auto, home, and commercial coverage.
Read more on TRV →